BillionaireNet
family
Cao Longxiang & family
Rank #1421
CHINAHealthcarePharmaceuticals

Cao Longxiang & family

Net Worth
$2.826B
-0.28% (24h)
Cao Longxiang, at 68 years old, is the chairman of Hubei Jumpcan Pharmaceutical, a major player in China's pharmaceutical industry. His estimated net worth is $2.8 billion, a testament to his success in the healthcare sector. Cao's wealth stems from his leadership of Hubei Jumpcan Pharmaceutical, which specializes in both Western and traditional Chinese medicine. His career began outside the pharmaceutical industry, and his journey to becoming a billionaire involved a transition from a cement factory manager to the head of a significant pharmaceutical company. Cao's son, Cao Fei, serves as the vice chairman of Hubei Jumpcan Pharmaceutical. As of December 16, 2025, his real-time net worth reflects a change since the previous trading day, and he is ranked #1409 globally.

The Full Dossier

Early Life

Cao Longxiang's career path began outside of the pharmaceutical industry. Before entering the healthcare sector, he worked as a manager at a cement factory and served in the Chinese military.

Rise to Success

Cao's path to success in the pharmaceutical industry began when he took a job with Hubei Jumpcan Pharmaceutical. He later became the chairman of the company, which is one of China's largest drug companies specializing in both Western and traditional Chinese medicine. Cao took control of the company in 2013 and now owns more than 60% of the company.

Key Business Strategies

Under Cao's leadership, Hubei Jumpcan Pharmaceutical has focused on both Western and traditional Chinese medicine. The company went public in 2001 as Hubei Hongcheng General Machinery.

Family

Cao's son, Cao Fei, serves as the vice chairman of Hubei Jumpcan Pharmaceutical.

Career Timeline

2013

Cao Longxiang took control of the company

Cao became the controlling shareholder of Hubei Jumpcan Pharmaceutical, owning over 60%.

2001

Hubei Hongcheng General Machinery went public

The company, which Cao Longxiang chairs, went public.

Wealth Trajectory